News

Media

Conferences

Publications

Clinical

Events

Resources

Video

September 21, 2016

Were PCSK9 Inhibitors Overhyped?

Author(s):

Lauren Santye, Assistant Editor

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Related Videos

Pharmacist and a patient -- Image credit: Zamrznuti tonovi | stock.adobe.com

October is American Pharmacists Month.

American Pharmacist Month | Image Credit: Zoran Zeremski - stock.adobe.com

smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background

Patient receiving cancer care from provider -- Image credit: Rido | stock.adobe.com

Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com

Artificial intelligence in health care -- Image credit: Martinesku | stock.adobe.com

Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications

Pharmacy School, social media, non-traditional learning | Image Credit: Ахтем - stock.adobe.com

Children's doctor vaccinating little boy at home.

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.